CN104099425B - 一种用于检测B-raf基因突变的试剂盒 - Google Patents
一种用于检测B-raf基因突变的试剂盒 Download PDFInfo
- Publication number
- CN104099425B CN104099425B CN201410377953.XA CN201410377953A CN104099425B CN 104099425 B CN104099425 B CN 104099425B CN 201410377953 A CN201410377953 A CN 201410377953A CN 104099425 B CN104099425 B CN 104099425B
- Authority
- CN
- China
- Prior art keywords
- primer
- probe
- raf
- mark
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101100381978 Mus musculus Braf gene Proteins 0.000 title claims abstract description 80
- 238000012360 testing method Methods 0.000 title claims abstract description 44
- KKVYYGGCHJGEFJ-UHFFFAOYSA-N 1-n-(4-chlorophenyl)-6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine Chemical compound N=1C=CC2=C(NC=3C(=CC=CN=3)C=3C=4N=CNC=4N=CN=3)C(C)=CC=C2C=1NC1=CC=C(Cl)C=C1 KKVYYGGCHJGEFJ-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 239000000523 sample Substances 0.000 claims abstract description 135
- 238000001514 detection method Methods 0.000 claims abstract description 53
- 239000002773 nucleotide Substances 0.000 claims abstract description 49
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 49
- 238000003908 quality control method Methods 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- 230000003321 amplification Effects 0.000 claims abstract description 29
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 29
- 239000011259 mixed solution Substances 0.000 claims abstract description 28
- 230000035772 mutation Effects 0.000 claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 claims abstract description 6
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 23
- 238000011144 upstream manufacturing Methods 0.000 claims description 17
- 230000008859 change Effects 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 14
- 239000013641 positive control Substances 0.000 claims description 14
- 238000013016 damping Methods 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- 108010006785 Taq Polymerase Proteins 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000026731 phosphorylation Effects 0.000 claims description 4
- 238000006366 phosphorylation reaction Methods 0.000 claims description 4
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 3
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract 1
- 238000000034 method Methods 0.000 description 22
- 206010064571 Gene mutation Diseases 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 241000239226 Scorpiones Species 0.000 description 4
- 208000024770 Thyroid neoplasm Diseases 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 201000002510 thyroid cancer Diseases 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 208000033781 Thyroid carcinoma Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 101150048834 braF gene Proteins 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 238000012875 competitive assay Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 238000002944 PCR assay Methods 0.000 description 2
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 2
- 229940121647 egfr inhibitor Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940082789 erbitux Drugs 0.000 description 1
- 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410377953.XA CN104099425B (zh) | 2014-08-01 | 2014-08-01 | 一种用于检测B-raf基因突变的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410377953.XA CN104099425B (zh) | 2014-08-01 | 2014-08-01 | 一种用于检测B-raf基因突变的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104099425A CN104099425A (zh) | 2014-10-15 |
CN104099425B true CN104099425B (zh) | 2015-12-02 |
Family
ID=51667963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410377953.XA Active CN104099425B (zh) | 2014-08-01 | 2014-08-01 | 一种用于检测B-raf基因突变的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104099425B (zh) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104611406A (zh) * | 2013-11-04 | 2015-05-13 | 江苏默乐生物科技有限公司 | B-raf基因V600E突变检测的方法 |
CN105986018A (zh) * | 2015-02-06 | 2016-10-05 | 上海赛安生物医药科技有限公司 | Nras基因突变检测体系及其试剂盒 |
CN105986017A (zh) * | 2015-02-06 | 2016-10-05 | 上海赛安生物医药科技有限公司 | Pdgfra基因突变检测体系及其试剂盒 |
CN105063177A (zh) * | 2015-05-14 | 2015-11-18 | 广州和实生物技术有限公司 | Braf基因多点突变单管快速检测方法及试剂盒 |
CN104846106B (zh) * | 2015-05-29 | 2018-04-27 | 沈阳优吉诺生物科技有限公司 | 检测braf基因v600e突变位点的引物、试剂盒及其pcr方法 |
CN105039514A (zh) * | 2015-06-02 | 2015-11-11 | 武汉友芝友医疗科技有限公司 | 人类braf基因v600e突变检测试剂盒 |
CN105296666A (zh) * | 2015-12-07 | 2016-02-03 | 湖南圣维基因科技有限公司 | 一种braf基因v600e突变荧光pcr检测试剂盒 |
CN106434938A (zh) * | 2016-10-17 | 2017-02-22 | 上海赛安生物医药科技有限公司 | 结直肠癌检测引物探针及其试剂盒 |
CN108070653A (zh) * | 2016-11-15 | 2018-05-25 | 江苏众红生物工程创药研究院有限公司 | 用于人braf基因突变检测的试剂盒及其应用 |
CN106755376A (zh) * | 2016-12-12 | 2017-05-31 | 厦门飞朔生物技术有限公司 | 一种用于检测b‑raf基因突变的多重荧光pcr检测试剂盒 |
CN106868127B (zh) * | 2017-02-20 | 2019-09-10 | 人和未来生物科技(长沙)有限公司 | 人kras基因多点突变单管联检荧光pcr方法、试剂盒及体系 |
CN107177682A (zh) * | 2017-06-13 | 2017-09-19 | 安徽安龙基因医学检验所有限公司 | 用于brafv600e基因突变的试剂盒及检测方法 |
CN109136367B (zh) * | 2017-06-19 | 2022-03-18 | 格诺思博生物科技南通有限公司 | 提高braf基因v600e突变的诊断效率的方法 |
CN107400716A (zh) * | 2017-08-24 | 2017-11-28 | 上海生物芯片有限公司 | 人braf基因v600e突变的pcr检测方法、引物、探针及试剂盒 |
CN108048569A (zh) * | 2017-12-27 | 2018-05-18 | 广州誉嘉生物科技有限公司 | Braf基因突变检测的引物和探针及应用 |
CN109971832A (zh) * | 2017-12-28 | 2019-07-05 | 浙江数问生物技术有限公司 | 一种检测基因突变的试剂盒、方法及其用途 |
CN108300785A (zh) * | 2018-02-13 | 2018-07-20 | 无锡禾盛医疗器械有限公司 | 一种braf基因突变检测的引物探针组合及其应用 |
CN109234369A (zh) * | 2018-10-21 | 2019-01-18 | 上海睿璟生物科技有限公司 | 一种检测人braf基因突变的pcr试剂盒 |
CN111607646A (zh) * | 2019-02-26 | 2020-09-01 | 成都华青精准医疗科技有限公司 | 一种用于检测braf基因突变的核苷酸序列组及其应用 |
CN110656175A (zh) * | 2019-09-12 | 2020-01-07 | 上海药明康德医学检验所有限公司 | 靶向测序gDNA对照品及其制备方法 |
CN110714096A (zh) * | 2019-10-17 | 2020-01-21 | 深圳市疾病预防控制中心 | 一种用于同时检测4种登革热病毒分型的试剂盒 |
CN110964818A (zh) * | 2019-11-28 | 2020-04-07 | 重庆浦洛通基因医学研究院有限公司 | 一种人类braf基因v600e突变的检测试剂盒及检测方法 |
CN110951849B (zh) * | 2019-12-30 | 2023-09-19 | 武汉光谷联合医学检验实验室股份有限公司 | 一种用于检测人类B-raf基因突变的PCR试剂盒及其应用 |
CN112951325B (zh) * | 2021-02-18 | 2023-04-21 | 北京吉因加医学检验实验室有限公司 | 一种用于癌症检测的探针组合的设计方法及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102816851A (zh) * | 2012-08-29 | 2012-12-12 | 苏州旷远生物分子技术有限公司 | 用于检测braf基因v600e突变的引物、探针、试剂盒及方法 |
-
2014
- 2014-08-01 CN CN201410377953.XA patent/CN104099425B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104099425A (zh) | 2014-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104099425B (zh) | 一种用于检测B-raf基因突变的试剂盒 | |
CN104805208B (zh) | 用于检测人类kras基因7种热点突变的引物探针组合物、试剂盒及检测方法 | |
CN103710460B (zh) | 定量检测egfr基因突变的试剂盒及其用途 | |
CN102242207B (zh) | 癌基因brafv600e突变检测的引物和探针 | |
CN103074434B (zh) | 一种cyp2c19基因多态性检测试剂盒及其检测方法 | |
US20140017682A1 (en) | High resolution melting analysis as a prescreening tool | |
CN104805207A (zh) | 检测kras基因突变的试剂盒及其检测方法 | |
CN103695555A (zh) | K-ras基因8种突变荧光分型检测试剂盒及检测方法 | |
CN103074436B (zh) | 一种指导5-氟尿嘧啶用药的多重基因检测试剂盒及其检测方法 | |
CN107447013B (zh) | 检测Kras基因第12、13密码子突变位点的方法及其试剂盒 | |
WO2006106316A2 (en) | Polynucleotide primers | |
CN108841953A (zh) | 利用数字pcr技术检测egfr基因22种突变的试剂盒 | |
CN104805206A (zh) | 检测tert基因启动子突变的试剂盒及其检测方法 | |
CN104232781A (zh) | 一种检测HLA-B*5801等位基因的TaqMan探针实时荧光PCR方法 | |
CN105274096A (zh) | 桥式序列区掺入错配碱基的桥式荧光探针及其应用和方法 | |
CN105349680A (zh) | Pik3ca基因突变核酸检测试剂盒 | |
CN107988369A (zh) | 一种同时检测人egfr基因45个突变位点的试剂盒 | |
CN107513577A (zh) | 一种高效检测egfrt790m突变体的方法以及用于检测的探针和试剂盒 | |
CN104846106A (zh) | 检测braf基因v600e突变位点的引物、试剂盒及其pcr方法 | |
CN104531881A (zh) | 一种人k-ras基因突变荧光pcr检测试剂盒 | |
CN103074438B (zh) | 一种指导华法林用药的多重基因检测试剂盒及其检测方法 | |
CN104818340A (zh) | 检测jak2基因v617f位点多态性的引物、试剂盒及其pcr方法 | |
CN105969908A (zh) | Ctnnb1第三外显子突变检测引物探针及其试剂盒 | |
MX2015003386A (es) | Metodo para la deteccion de mutaciones de braf y pi3k. | |
CN106811537A (zh) | 一种检测表皮生长因子受体基因t790m低频突变引物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201020 Address after: 274000 No. 2888 Zhonghua West Road, hi tech Zone, Shandong, Heze Patentee after: GUOJIUTANG SHANDONG DONKEY-HIDE GELATIN Co.,Ltd. Address before: 200436, Shanghai, Baoshan District, Shanghai Road, No. 1888, Wen Sheng building, 1 floor Patentee before: SHANGHAI SHINES PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: No.2888, Zhonghua West Road, hi tech Zone, Heze City, Shandong Province 274000 Patentee after: Shandong Guojiutang Pharmaceutical Group Co.,Ltd. Address before: No.2888, Zhonghua West Road, hi tech Zone, Heze City, Shandong Province 274000 Patentee before: GUOJIUTANG SHANDONG DONKEY-HIDE GELATIN CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |